Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

Por Cappelletti, Maria Rosa, Gnetti, Letizia, Santini, Daniele, Spada, Daniele, Fox, Stephen B., Generali, Daniele
Publicado no Oncoscience (2015)

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA

Por Del Re, Marzia, Tiseo, Marcello, Bordi, Paola, D'Incecco, Armida, Camerini, Andrea, Petrini, Iacopo, Lucchesi, Maurizio, Inno, Alessandro, Spada, Daniele, Vasile, Enrico, Citi, Valentina, Malpeli, Giorgio, Testa, Enrica, Gori, Stefania, Falcone, Alfredo, Amoroso, Domenico, Chella, Antonio, Cappuzzo, Federico, Ardizzoni, Andrea, Scarpa, Aldo, Danesi, Romano
Publicado no Oncotarget (2016)